Gorizio Pieretti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gorizio Pieretti has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Maria Giovanna Vastarella
Department of Woman, Child and General and Special Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
6 shared publications - Feliciano Ciccarelli
Department of Plastic Surgery, Villa dei Fiori Hospital, Acerra, Italy
5 shared publications - Maria Consiglia Trotta
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
4 shared publications - Michele D' Amico
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
4 shared publications - Anca Hermenean
“Aurel Ardelean” Institute of Life Sciences, “Vasile Goldiș” Western University of Arad, 310025 Arad, Romania
3 shared publications - Celestino Sardu
Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8828
Abdominal Body Contouring After Bariatric, Pharmacological, and Combined Weight Loss: A Narrative Review and Clinical Decision Framework
Abdominal body contouring after substantial weight loss increasingly involves patients treated by bariatric surgery, incretin-based pharmacotherapy, or both. This focused narrative review updates surgical planning across these trajectories, with emphasis on timing, nutritional and hematological preparation, procedure selection, perioperative incretin management, complications, and patient-reported outcomes. The original structured PubMed searches were supplemented during revision by a focused screen of comparative incretin/body-contouring studies and primary perioperative aspiration studies through 24 October 2026. Comparative body-contouring evidence remains observational and heterogeneous: some cohorts report no independent modality effect, whereas others associate GLP-1 receptor agonist exposure, rapid weight loss, or combined treatment with selected wound complications. Two recent meta-analyses similarly identify limited and inconsistent signals rather than a uniform risk pattern. Gastric-ultrasound studies demonstrate more residual gastric content in semaglutide users, but clinical aspiration data are conflicting, supporting individualized anesthetic assessment rather than a universal interruption interval. Practical assessment should integrate weight trajectory, achieved intake, anemia and micronutrient risk, anatomical deformity, psychological readiness, venous-thromboembolism risk, abdominal-wall pathology, and the cumulative recovery burden of combined procedures. Comparative evidence supports dead-space reduction and consideration of Scarpa fascia preservation for seroma prevention. A proposed decision framework distinguishes evidence from professional guidance and review-derived clinical judgment. The framework is not a validated prediction instrument and requires prospective evaluation.
- 11 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8828
Open AccessAbdominal Body Contouring After Bariatric, Pharmacological, and Combined Weight Loss: A Narrative Review and Clinical Decision Framework
Abdominal body contouring after substantial weight loss increasingly involves patients treated by bariatric surgery, incretin-based pharmacotherapy, or both. This focused narrative review updates surgical planning across these trajectories, with emphasis on timing, nutritional and hematological preparation, procedure selection, perioperative incretin management, complications, and patient-reported outcomes. The original structured PubMed searches were supplemented during revision by a focused screen of comparative incretin/body-contouring studies and primary perioperative aspiration studies through 24 October 2026. Comparative body-contouring evidence remains observational and heterogeneous: some cohorts report no independent modality effect, whereas others associate GLP-1 receptor agonist exposure, rapid weight loss, or combined treatment with selected wound complications. Two recent meta-analyses similarly identify limited and inconsistent signals rather than a uniform risk pattern. Gastric-ultrasound studies demonstrate more residual gastric content in semaglutide users, but clinical aspiration data are conflicting, supporting individualized anesthetic assessment rather than a universal interruption interval. Practical assessment should integrate weight trajectory, achieved intake, anemia and micronutrient risk, anatomical deformity, psychological readiness, venous-thromboembolism risk, abdominal-wall pathology, and the cumulative recovery burden of combined procedures. Comparative evidence supports dead-space reduction and consideration of Scarpa fascia preservation for seroma prevention. A proposed decision framework distinguishes evidence from professional guidance and review-derived clinical judgment. The framework is not a validated prediction instrument and requires prospective evaluation.
- Open Access
- 8 August 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (8) , 1249
Semaglutide Exposure During Pregnancy: Results from the FAERS Database
Background/Objectives: The increased incidence of obesity and type 2 diabetes, along with the growing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), particularly semaglutide, among women of childbearing age makes it especially important to assess their safety profile during pregnancy. Methods: A post-marketing study was conducted using reports from the U.S. FDA Adverse Event Reporting System (FAERS) database (2017–2025). Descriptive analyses focused on pregnancy outcomes and fetal/neonatal disorders. Disproportionality analyses assessed adverse event (AE) reporting by System Organ Class (SOC) and pregnancy-related AEs associated with semaglutide versus other medications. A Standardized MedDRA Query (SMQ)-based disproportionality analysis was also performed. Results: A total of 249 cases involving semaglutide use during pregnancy were identified, comprising 922 AEs. “Injury, poisoning and procedural complications” was the most frequently reported SOC, while abortion- and pregnancy loss-related events accounted for 27.3% of reported AEs. Compared with other medications, semaglutide showed higher reporting odds for “Pregnancy, puerperium and perinatal conditions” (ROR 1.59; 95% CI 1.37–1.86), “Injury, poisoning and procedural complications” (ROR 1.93; 95% CI 1.70–2.20), and gastrointestinal disorders (ROR 1.72; 95% CI 1.38–2.15), with no significant association for “Congenital, familial and genetic disorders” or “Reproductive system and breast disorders”. SMQ-based analysis showed increased reporting odds for “Termination of pregnancy and risk of abortion” (ROR 3.71; 95% CI 3.07–4.48). Conclusions: Disproportionate reporting was identified for pregnancy- and perinatal-related events, procedural/exposure-related complications, and pregnancy termination, with no evidence of a disproportionate congenital-anomaly signal. These findings should be interpreted cautiously and do not necessarily indicate a causal association.
- 8 August 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (8) , 1249
Open AccessSemaglutide Exposure During Pregnancy: Results from the FAERS Database
Background/Objectives: The increased incidence of obesity and type 2 diabetes, along with the growing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), particularly semaglutide, among women of childbearing age makes it especially important to assess their safety profile during pregnancy. Methods: A post-marketing study was conducted using reports from the U.S. FDA Adverse Event Reporting System (FAERS) database (2017–2025). Descriptive analyses focused on pregnancy outcomes and fetal/neonatal disorders. Disproportionality analyses assessed adverse event (AE) reporting by System Organ Class (SOC) and pregnancy-related AEs associated with semaglutide versus other medications. A Standardized MedDRA Query (SMQ)-based disproportionality analysis was also performed. Results: A total of 249 cases involving semaglutide use during pregnancy were identified, comprising 922 AEs. “Injury, poisoning and procedural complications” was the most frequently reported SOC, while abortion- and pregnancy loss-related events accounted for 27.3% of reported AEs. Compared with other medications, semaglutide showed higher reporting odds for “Pregnancy, puerperium and perinatal conditions” (ROR 1.59; 95% CI 1.37–1.86), “Injury, poisoning and procedural complications” (ROR 1.93; 95% CI 1.70–2.20), and gastrointestinal disorders (ROR 1.72; 95% CI 1.38–2.15), with no significant association for “Congenital, familial and genetic disorders” or “Reproductive system and breast disorders”. SMQ-based analysis showed increased reporting odds for “Termination of pregnancy and risk of abortion” (ROR 3.71; 95% CI 3.07–4.48). Conclusions: Disproportionate reporting was identified for pregnancy- and perinatal-related events, procedural/exposure-related complications, and pregnancy termination, with no evidence of a disproportionate congenital-anomaly signal. These findings should be interpreted cautiously and do not necessarily indicate a causal association.
- Open Access
Glandular Transposition Technique for the Correction of Advanced Gynecomastia in Post-Bariatric Patients: A Case Series on a Conservative Strategy for Natural Aesthetic Outcomes
Background and Objectives: Advanced gynecomastia/pseudogynecomastia (Simon grades IIb–III) in post-bariatric patients presents both esthetic and technical challenges. Conventional excisional methods often result in flattened chest contours, extensive scarring, and loss of nipple–areolar complex (NAC) sensation. There is a growing need for conservative, tissue-preserving strategies that respect the unique morphology of massive weight-loss patients. Materials and Methods: This consecutive case series included 15 male patients (median age: 38 years, IQR 36.5–39.5) with advanced gynecomastia/pseudogynecomastia and stable weight loss following bariatric surgery. All underwent a glandular transposition technique, preserving the NAC on a pedicle based on thoracic perforators and avoiding free grafting. Redundant lower-pole skin was excised, a new NAC site was created cranially, and the gland was repositioned beneath a dermo-adipose flap. Outcomes included complication rates, patient satisfaction, and changes in BODY-Q chest appearance scores. Results: No major complications occurred. NAC viability and sensation were preserved in all patients. One patient required secondary revision for residual contour bulging, while three developed minor hematomas that resolved spontaneously. At 3 months, the median Likert satisfaction score improved from 2 (IQR 2–3) preoperatively to 5 (IQR 4–5) postoperatively (p < 0.001, Wilcoxon signed-rank test). BODY-Q chest appearance scores improved significantly from 31 (IQR 28–35) to 78 (IQR 74–82) (p < 0.001). External observers preferred postoperative results in 90% of randomized photo-pair comparisons. Conclusions: Glandular transposition is a safe, reproducible, and esthetically effective technique for advanced gynecomastia/pseudogynecomastia in post-bariatric men. By preserving glandular continuity and avoiding free NAC grafting, this method achieves natural chest projection, maintains nipple sensitivity, and provides high patient satisfaction with minimal complications. It represents a compelling alternative to conventional radical excision strategies.
Open AccessGlandular Transposition Technique for the Correction of Advanced Gynecomastia in Post-Bariatric Patients: A Case Series on a Conservative Strategy for Natural Aesthetic Outcomes
Background and Objectives: Advanced gynecomastia/pseudogynecomastia (Simon grades IIb–III) in post-bariatric patients presents both esthetic and technical challenges. Conventional excisional methods often result in flattened chest contours, extensive scarring, and loss of nipple–areolar complex (NAC) sensation. There is a growing need for conservative, tissue-preserving strategies that respect the unique morphology of massive weight-loss patients. Materials and Methods: This consecutive case series included 15 male patients (median age: 38 years, IQR 36.5–39.5) with advanced gynecomastia/pseudogynecomastia and stable weight loss following bariatric surgery. All underwent a glandular transposition technique, preserving the NAC on a pedicle based on thoracic perforators and avoiding free grafting. Redundant lower-pole skin was excised, a new NAC site was created cranially, and the gland was repositioned beneath a dermo-adipose flap. Outcomes included complication rates, patient satisfaction, and changes in BODY-Q chest appearance scores. Results: No major complications occurred. NAC viability and sensation were preserved in all patients. One patient required secondary revision for residual contour bulging, while three developed minor hematomas that resolved spontaneously. At 3 months, the median Likert satisfaction score improved from 2 (IQR 2–3) preoperatively to 5 (IQR 4–5) postoperatively (p < 0.001, Wilcoxon signed-rank test). BODY-Q chest appearance scores improved significantly from 31 (IQR 28–35) to 78 (IQR 74–82) (p < 0.001). External observers preferred postoperative results in 90% of randomized photo-pair comparisons. Conclusions: Glandular transposition is a safe, reproducible, and esthetically effective technique for advanced gynecomastia/pseudogynecomastia in post-bariatric men. By preserving glandular continuity and avoiding free NAC grafting, this method achieves natural chest projection, maintains nipple sensitivity, and provides high patient satisfaction with minimal complications. It represents a compelling alternative to conventional radical excision strategies.
- Open Access
- 24 June 2025
- Published by MDPI AG in Preprints.org
Impact of Abdominoplasty on the Quality of Life of Post-Bariatric Patients
Objective: This study aimed to assess the impact of abdominoplasty on the quality of life (QoL) of post-bariatric patients. Methodology: A cohort of 100 post-bariatric patients, aged 27 to 59 years with a preoperative body mass index (BMI) up to 30 kg/m², were selected for this cross-sectional survey study. Participants were non-smokers, non-diabetics, and had no additional surgical procedures beyond abdominoplasty. QoL was evaluated using a modified version of the IQMWL test, adapted to a binary “Satisfied” or “Unsatisfied” response format to enhance clarity and facilitate telephone-based data collection. Assessments occurred preoperatively and one year postoperatively via anonymous telephone interviews conducted by an independent staff member to minimize bias. The questionnaire covered seven domains: general health, social relations, mobility, self-esteem, dietary comfort, sexual life, and work performance. McNemar’s test was applied to analyze changes in satisfaction levels across these dimensions. Results: Preoperative dissatisfaction was prevalent, with only 24% satisfied with general health, 32% with social relations, 26% with mobility, 11% with self-esteem, 30% with dietary comfort, 42% with sexual life, and 45% with work performance. One-year post-abdominoplasty, significant improvements emerged: satisfaction rose to 83% for general health, 90% for social relations, 88% for mobility, 84% for self-esteem, 60% for dietary comfort, 92% for sexual life, and 93% for work performance (all p < 0.05). These shifts reflected enhanced physical functionality, psychological well-being, and social confidence, with the greatest turnovers in self-esteem, sexual life, and work performance. Conclusion: Abdominoplasty markedly improved QoL in post-bariatric patients across all assessed domains, extending beyond cosmetic benefits to enhance physical health, psychological resilience, and social integration. Limitations include a one-year follow-up and lack of complication data, suggesting a need for longer-term studies. Keywords: Abdominoplasty, post-bariatric surgery, quality of life, IQMWL test, self-esteem, mobility, sexual life
- 24 June 2025
- Published by MDPI AG in Preprints.org
Open AccessImpact of Abdominoplasty on the Quality of Life of Post-Bariatric Patients
Objective: This study aimed to assess the impact of abdominoplasty on the quality of life (QoL) of post-bariatric patients. Methodology: A cohort of 100 post-bariatric patients, aged 27 to 59 years with a preoperative body mass index (BMI) up to 30 kg/m², were selected for this cross-sectional survey study. Participants were non-smokers, non-diabetics, and had no additional surgical procedures beyond abdominoplasty. QoL was evaluated using a modified version of the IQMWL test, adapted to a binary “Satisfied” or “Unsatisfied” response format to enhance clarity and facilitate telephone-based data collection. Assessments occurred preoperatively and one year postoperatively via anonymous telephone interviews conducted by an independent staff member to minimize bias. The questionnaire covered seven domains: general health, social relations, mobility, self-esteem, dietary comfort, sexual life, and work performance. McNemar’s test was applied to analyze changes in satisfaction levels across these dimensions. Results: Preoperative dissatisfaction was prevalent, with only 24% satisfied with general health, 32% with social relations, 26% with mobility, 11% with self-esteem, 30% with dietary comfort, 42% with sexual life, and 45% with work performance. One-year post-abdominoplasty, significant improvements emerged: satisfaction rose to 83% for general health, 90% for social relations, 88% for mobility, 84% for self-esteem, 60% for dietary comfort, 92% for sexual life, and 93% for work performance (all p < 0.05). These shifts reflected enhanced physical functionality, psychological well-being, and social confidence, with the greatest turnovers in self-esteem, sexual life, and work performance. Conclusion: Abdominoplasty markedly improved QoL in post-bariatric patients across all assessed domains, extending beyond cosmetic benefits to enhance physical health, psychological resilience, and social integration. Limitations include a one-year follow-up and lack of complication data, suggesting a need for longer-term studies. Keywords: Abdominoplasty, post-bariatric surgery, quality of life, IQMWL test, self-esteem, mobility, sexual life
- Open Access
- 25 June 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (7) , 681
Experience in Post-Bariatric Abdominoplasty for Patients with Significant Weight Loss: A Prospective Study
Background: Abdominoplasty is a critical aesthetic and functional procedure for individuals who have undergone massive weight loss. Numerous techniques have been proposed to optimize aesthetic results while minimizing complications. Methods: This prospective study examined 500 patients who underwent abdominoplasty during body-contouring procedures between 1 January 2018 and 31 December 2021 at a tertiary center. The Skin–Adipose Tissue–Muscle (SAM) protocol was employed to analyze the operative strategies and complication rates and compare them with the existing literature. Furthermore, patient satisfaction and aesthetic outcomes were measured one year post-operation using a comprehensive four-point questionnaire evaluated by the patients themselves and two independent surgeons. Results: Participants had an average age of 34.8 years and a mean BMI of 31.1 kg/m2. The surgeries included 328 full abdominoplasties and 172 T-inverted abdominoplasties. Notable complications included wound infection (4%), wound dehiscence (8.6%), tissue necrosis (0.6%), seroma (8.4%), and hematoma (2.6%). A higher BMI was correlated with an increased risk of complications and lower patient satisfaction. Data analysis was performed using Stata version 18 software. Conclusions: The increasing prevalence of obesity highlights an urgent need for more bariatric surgeries and subsequent abdominoplasties to mitigate the effects of massive weight loss. A crucial link between elevated BMI and a heightened risk of postoperative complications, emphasizing the necessity for standardized surgical protocols tailored to individuals with higher BMI, was noted. Innovatively, future studies must further investigate the intricate dynamics between BMI and surgical risks. Exploring and establishing uniform, adaptive surgical guidelines promise to revolutionize patient care by significantly reducing complications and enhancing recovery and satisfaction following abdominoplasty.
- 25 June 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (7) , 681
Open AccessExperience in Post-Bariatric Abdominoplasty for Patients with Significant Weight Loss: A Prospective Study
Background: Abdominoplasty is a critical aesthetic and functional procedure for individuals who have undergone massive weight loss. Numerous techniques have been proposed to optimize aesthetic results while minimizing complications. Methods: This prospective study examined 500 patients who underwent abdominoplasty during body-contouring procedures between 1 January 2018 and 31 December 2021 at a tertiary center. The Skin–Adipose Tissue–Muscle (SAM) protocol was employed to analyze the operative strategies and complication rates and compare them with the existing literature. Furthermore, patient satisfaction and aesthetic outcomes were measured one year post-operation using a comprehensive four-point questionnaire evaluated by the patients themselves and two independent surgeons. Results: Participants had an average age of 34.8 years and a mean BMI of 31.1 kg/m2. The surgeries included 328 full abdominoplasties and 172 T-inverted abdominoplasties. Notable complications included wound infection (4%), wound dehiscence (8.6%), tissue necrosis (0.6%), seroma (8.4%), and hematoma (2.6%). A higher BMI was correlated with an increased risk of complications and lower patient satisfaction. Data analysis was performed using Stata version 18 software. Conclusions: The increasing prevalence of obesity highlights an urgent need for more bariatric surgeries and subsequent abdominoplasties to mitigate the effects of massive weight loss. A crucial link between elevated BMI and a heightened risk of postoperative complications, emphasizing the necessity for standardized surgical protocols tailored to individuals with higher BMI, was noted. Innovatively, future studies must further investigate the intricate dynamics between BMI and surgical risks. Exploring and establishing uniform, adaptive surgical guidelines promise to revolutionize patient care by significantly reducing complications and enhancing recovery and satisfaction following abdominoplasty.
- 19 January 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (5) , 827-828
Letter on “Modified Levator Resection Technique for Moderate Congenital Blepharoptosis”
- 19 January 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (5) , 827-828
Letter on “Modified Levator Resection Technique for Moderate Congenital Blepharoptosis”
- Open Access
Efficacy of a Novel Rigenase® and Polyhexanide (Fitostimoline® Septagel) Hydrogel Device for the Treatment of Vulvovaginitis Symptoms: Cross-Sectional Analysis of a National Survey and Prospective Observational Study
Background and Objectives: Signs and symptoms of vulvovaginitis, especially when recurrent, have a significant impact on a woman’s quality of life. The aim of this study was to survey gynecologists about their habits regarding the treatments of the pathology and to evaluate the efficacy of a novel vaginal hydrogel composed of wheat extracts and polyhexanide aimed at reducing vulvovaginitis symptomatology. Materials and Methods: A cross-sectional analysis of a national survey using 155 Italian gynecologists and a prospective, open-label, observational study were carried out in 75 outpatient clinics across Italy. Pre- and postmenopausal women with suspicion of vulvovaginitis due to at least four of the following symptoms (leucoxanthorrhea, bad odor from genitalia, vulvovaginal dryness, petechiae, burning, and pruritus) while waiting for microbiological swab analysis were included and treated with one hydrogel application every 3 days for 1 week. Primary endpoint was the complete resolution of symptomatology. Results: The pre-study survey reported that, for most clinicians, local or oral treatment (65.7% and 82.8%, respectively) with antibiotics or antifungals is used very often. Therefore, we proceeded to carry out an observational study. Overall, 615 (362 of fertile age and 253 in postmenopause) women were included in this study. At the 28th follow-up examination, complete resolution of symptomatology was achieved in 578/615 (94.1%; p < 0.001) within 12.72 ± 6.55 and 13.22 ± 6.33 days for those of fertile age and in postmenopause, respectively (p = 0.342). All of the evaluated symptoms were significantly reduced after treatment (p = 0.001) without differences according to the patient’s menopausal status. A slightly significant reduction in Gardnerella Vaginalis (p = 0.040) and Candida Albicans (p = 0.049) was found after treatment. No patient reported side effects, adverse reactions, or discontinued therapy. Conclusions: This pilot study showed that a hydrogel based on Rigenase® (wheat extract) and polyhexanide could be a promising treatment for the relief of vulvovaginitis symptoms. However, these results are limited by the absence of a control group. Additional comparative and randomized controlled trials between the hydrogel and other non-antibiotic devices as well as local antibiotic therapy should be performed to increase the validity of the findings.
Open AccessEfficacy of a Novel Rigenase® and Polyhexanide (Fitostimoline® Septagel) Hydrogel Device for the Treatment of Vulvovaginitis Symptoms: Cross-Sectional Analysis of a National Survey and Prospective Observational Study
Background and Objectives: Signs and symptoms of vulvovaginitis, especially when recurrent, have a significant impact on a woman’s quality of life. The aim of this study was to survey gynecologists about their habits regarding the treatments of the pathology and to evaluate the efficacy of a novel vaginal hydrogel composed of wheat extracts and polyhexanide aimed at reducing vulvovaginitis symptomatology. Materials and Methods: A cross-sectional analysis of a national survey using 155 Italian gynecologists and a prospective, open-label, observational study were carried out in 75 outpatient clinics across Italy. Pre- and postmenopausal women with suspicion of vulvovaginitis due to at least four of the following symptoms (leucoxanthorrhea, bad odor from genitalia, vulvovaginal dryness, petechiae, burning, and pruritus) while waiting for microbiological swab analysis were included and treated with one hydrogel application every 3 days for 1 week. Primary endpoint was the complete resolution of symptomatology. Results: The pre-study survey reported that, for most clinicians, local or oral treatment (65.7% and 82.8%, respectively) with antibiotics or antifungals is used very often. Therefore, we proceeded to carry out an observational study. Overall, 615 (362 of fertile age and 253 in postmenopause) women were included in this study. At the 28th follow-up examination, complete resolution of symptomatology was achieved in 578/615 (94.1%; p < 0.001) within 12.72 ± 6.55 and 13.22 ± 6.33 days for those of fertile age and in postmenopause, respectively (p = 0.342). All of the evaluated symptoms were significantly reduced after treatment (p = 0.001) without differences according to the patient’s menopausal status. A slightly significant reduction in Gardnerella Vaginalis (p = 0.040) and Candida Albicans (p = 0.049) was found after treatment. No patient reported side effects, adverse reactions, or discontinued therapy. Conclusions: This pilot study showed that a hydrogel based on Rigenase® (wheat extract) and polyhexanide could be a promising treatment for the relief of vulvovaginitis symptoms. However, these results are limited by the absence of a control group. Additional comparative and randomized controlled trials between the hydrogel and other non-antibiotic devices as well as local antibiotic therapy should be performed to increase the validity of the findings.
- 27 October 2023
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (1) , 433-434
Letter on: “Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life”
Authors comment on the paper “Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life” written by Abigail Meyers et al in Aesthetic Plastic Surgery. Although the authors present interesting results on the quality of life of patients after platelet-rich plasma, we express some considerations about the proposed composition of PRP and hoping in larger sample study. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266
- 27 October 2023
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (1) , 433-434
Letter on: “Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life”
Authors comment on the paper “Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life” written by Abigail Meyers et al in Aesthetic Plastic Surgery. Although the authors present interesting results on the quality of life of patients after platelet-rich plasma, we express some considerations about the proposed composition of PRP and hoping in larger sample study. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266
- 14 September 2023
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (21) , 4590-4591
Letter on: “Aesthetic, Quality-of-Life, and Clinical Outcomes after Inferior Pedicle Oncoplastic Reduction Mammoplasty”
Authors comment on the paper “Aesthetic, Quality of Life, and Clinical Outcomes after Inferior Pedicle Oncoplastic Reduction Mammoplasty” written by Thomas Y Xia et al. Although the authors present excellent results on Inferior Pedicle Oncoplastic Reduction Mammoplasty, we express some considerations about the proposed follow-up and hope in new research on this topic by Xia et al using his interesting data. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 14 September 2023
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (21) , 4590-4591
Letter on: “Aesthetic, Quality-of-Life, and Clinical Outcomes after Inferior Pedicle Oncoplastic Reduction Mammoplasty”
Authors comment on the paper “Aesthetic, Quality of Life, and Clinical Outcomes after Inferior Pedicle Oncoplastic Reduction Mammoplasty” written by Thomas Y Xia et al. Although the authors present excellent results on Inferior Pedicle Oncoplastic Reduction Mammoplasty, we express some considerations about the proposed follow-up and hope in new research on this topic by Xia et al using his interesting data. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Open Access
- 22 May 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (10) , 1513
Pelvic Organ Prolapse Syndrome and Lower Urinary Tract Symptom Update: What’s New?
(1) Background: This narrative review aimed to analyze the epidemiological, clinical, surgical, prognostic, and instrumental aspects of the link between pelvic organ prolapse (POP) and lower urinary tract symptoms (LUTS), collecting the most recent evidence from the scientific literature. (2) Methods: We matched the terms “pelvic organ prolapse” (POP) and “lower urinary tract symptoms” (LUTS) on the following databases: Pubmed, Embase, Scopus, Google scholar, and Cochrane. We excluded case reports, systematic reviews, articles published in a language other than English, and studies focusing only on a surgical technique. (3) Results: There is a link between POP and LUTS. Bladder outlet obstruction (BOO) would increase variation in bladder structure and function, which could lead to an overactive bladder (OAB). There is no connection between the POP stage and LUTS. Prolapse surgery could modify the symptoms of OAB with improvement or healing. Post-surgical predictive factors of non-improvement of OAB or de novo onset include high BMI, neurological pathologies, age > 65 years, and the severity of symptoms; predictors of emptying disorders are neurological pathologies, BOO, perineal dysfunctions, severity of pre-surgery symptoms, and severe anterior prolapse. Urodynamics should be performed on a specific subset of patients (i.e., stress urinary incontinence, correct surgery planning), (4) Conclusions: Correction of prolapse is the primary treatment for detrusor underactivity and for patients with both POP and OAB.
- 22 May 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (10) , 1513
Open AccessPelvic Organ Prolapse Syndrome and Lower Urinary Tract Symptom Update: What’s New?
(1) Background: This narrative review aimed to analyze the epidemiological, clinical, surgical, prognostic, and instrumental aspects of the link between pelvic organ prolapse (POP) and lower urinary tract symptoms (LUTS), collecting the most recent evidence from the scientific literature. (2) Methods: We matched the terms “pelvic organ prolapse” (POP) and “lower urinary tract symptoms” (LUTS) on the following databases: Pubmed, Embase, Scopus, Google scholar, and Cochrane. We excluded case reports, systematic reviews, articles published in a language other than English, and studies focusing only on a surgical technique. (3) Results: There is a link between POP and LUTS. Bladder outlet obstruction (BOO) would increase variation in bladder structure and function, which could lead to an overactive bladder (OAB). There is no connection between the POP stage and LUTS. Prolapse surgery could modify the symptoms of OAB with improvement or healing. Post-surgical predictive factors of non-improvement of OAB or de novo onset include high BMI, neurological pathologies, age > 65 years, and the severity of symptoms; predictors of emptying disorders are neurological pathologies, BOO, perineal dysfunctions, severity of pre-surgery symptoms, and severe anterior prolapse. Urodynamics should be performed on a specific subset of patients (i.e., stress urinary incontinence, correct surgery planning), (4) Conclusions: Correction of prolapse is the primary treatment for detrusor underactivity and for patients with both POP and OAB.